Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jama.230.3.372c | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Admission and goodbye letters from adolescents with anorexia nervosa in a day hospital.
BMC Psychiatry
March 2025
Fondation Santé des Etudiants de France (FSEF), Service Hospitalo-Universitaire de Santé Mentale de l'Adolescent et du Jeune Adulte (SHU-SMAJA), Paris, France.
Background: Care providers working with adolescents with anorexia nervosa (AN) encounter difficulties inherent in the illness (denial, ambivalence) and those related to the fact that it is most often the parents who bring adolescents to care units. Our aim was to study attitudes towards care among adolescents with AN treated in a specialised day hospital using an analysis of letters written before and after treatment.
Methods: Adolescents (12-20 years old) treated for AN in a specialised day hospital, providing multidisciplinary care while enabling a return to schooling inside the facility were included.
Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
World J Urol
March 2025
Department of Urology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Introduction: Disitamab Vedotin (DV, RC48, or RC48-ADC) is a novel humanized antibody-drug conjugate (ADC), which is based on human epidermal growth factor receptor 2 antibody (anti-HER2, or hertuzumab) coupled with monomethyl auristatin E (MMAE). This study aims to evaluate the efficacy and safety of RC48-ADC in combination with programmed cell death protein 1 (PD-1) inhibitors for treatment of locally advanced or metastatic urothelial carcinoma (la/mUC) patients.
Patients And Methods: This is a retrospective and real-world investigation originated from an enrollment of locally advanced or mUC patients underwent treatments with RC48-ADC in combination with PD-1 inhibitors in two hospitals, between August 2022 and July 2024.
Comment on "Survey on the Knowledge and Practices in Anorexia of Aging Diagnosis and Management in Japan" by Takagi et al.-The Authors' Reply.
J Cachexia Sarcopenia Muscle
April 2025
Department of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Furthering the benefits of DBT for eating disorders: a lived experience correspondence on McColl et al.
J Eat Disord
February 2025
Patient Representative, Royal College of Psychiatrists, London, UK.
This Correspondence article provides a lived experience perspective on McColl et al.'s study, which examines the use of Dialectical Behaviour Therapy for individuals with eating disorders. Drawing on experiences of DBT treatment for longstanding and severe anorexia, the author critically engages with the study's findings, highlighting both the strengths and limitations of the treatment approach McColl et al.
View Article and Find Full Text PDFBeneath the surface: unveiling the gut-brain axis in anorexia and depression.
Eat Weight Disord
February 2025
King Edward Medical University, Lahore, 54000, Pakistan.
Anorexia nervosa (AN) and depression are complex conditions with high comorbidity, impacting mental and physical health. Recent research suggests gut microbiota plays a significant role in their development and progression. This correspondence highlights the critical gaps in understanding the gut-brain axis in AN and depression, emphasizing the need for comprehensive research.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!